Journal of Movement Disorders

Hye-Young Sung

2 Articles

Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease: Joong-Seok Kim, Hye-Young Sung; J Mov Disord. 2015;8(2):76-82. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15008

40,903 View
261 Download
39 Citations

Currently, gastrointestinal dysfunctions in Parkinson’s disease (PD) are well-recognized problems and are known to be an initial symptom in the pathological process that eventually results in PD. Gastrointestinal symptoms may result from the involvement of either the central or enteric nervous systems, or these symptoms may be side effects of antiparkinsonian medications. Weight loss, excessive salivation, dysphagia, nausea/gastroparesis, constipation, and defecation dysfunction all may occur. Increased identification and early detection of these symptoms can result in a significant improvement in the quality of life for PD patients.

Citations

Citations to this article as recorded by

N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis
Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang
Brain Research Bulletin.2023; 202: 110729. CrossRef
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi
Anesthesiology and Pain Medicine.2023;[Epub] CrossRef
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi
CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008. CrossRef
A look back at the prodromal findings in Parkinson’s disease
Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
Bulletin of the National Research Centre.2023;[Epub] CrossRef
Nutritional aspects in Parkinson’s disease
Paulina Gątarek, Joanna Kałużna-Czaplińska
Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467. CrossRef
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
Nutrients.2022; 14(2): 380. CrossRef
Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang
Frontiers in Neurology.2022;[Epub] CrossRef
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen
European Journal of Inflammation.2022; 20: 1721727X2210837. CrossRef
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal
Folia Microbiologica.2022; 67(5): 693. CrossRef
Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi
Journal of Molecular Neuroscience.2022; 72(9): 1952. CrossRef
Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
Frontiers in Neurology.2022;[Epub] CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
Yasir Bashir, Asad U. Khan
Frontiers in Neuroscience.2022;[Epub] CrossRef
Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun
Microbial Pathogenesis.2021; 150: 104675. CrossRef
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
Acta Pharmaceutica Sinica B.2021;[Epub] CrossRef
Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl
International Journal of Molecular Sciences.2021; 22(6): 3233. CrossRef
Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye
Neurochemical Research.2021; 46(11): 3050. CrossRef
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness
Journal of Parkinson's Disease.2021; 11(4): 1821. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
Pharmacological Research.2021; 172: 105840. CrossRef
Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee
Brain, Behavior, and Immunity.2021; 98: 357. CrossRef
Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau
Neurotoxicity Research.2021; 39(6): 2141. CrossRef
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang
Microbiome.2021;[Epub] CrossRef
Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease
Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness
Neurogastroenterology & Motility.2020;[Epub] CrossRef
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa
European Journal of Pharmaceutical Sciences.2020; 147: 105280. CrossRef
Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa
Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano
Revista Brasileira de Geriatria e Gerontologia.2020;[Epub] CrossRef
Probiotics for Parkinson’s Disease
Gazerani
International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
Eliseu da Cruz Moreira-Junior
Medical Hypotheses.2019; 133: 109399. CrossRef
Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao
Current Neurovascular Research.2019; 16(3): 241. CrossRef
α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon
M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong
Neuroscience.2019; 423: 76. CrossRef
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen
Brain, Behavior, and Immunity.2018; 70: 48. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
Meng-Fei Sun, Yan-Qin Shen
Ageing Research Reviews.2018; 45: 53. CrossRef
Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
British Journal of Clinical Pharmacology.2018; 84(11): 2551. CrossRef
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial
Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab
Clinical Neuropharmacology.2018; 41(5): 151. CrossRef
Role of Microbiota in Neurodegenerative Diseases
C. V. Sobol
Russian Journal of Developmental Biology.2018; 49(6): 297. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
Neurological Sciences.2017; 38(1): 171. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim
Expert Review of Neurotherapeutics.2017; 17(7): 737. CrossRef
Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu
Brain Research.2016; 1642: 180. CrossRef
Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi
Parkinsonism & Related Disorders.2016;[Epub] CrossRef
An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient
Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park
Korean Journal of Spine.2015; 12(3): 153. CrossRef

The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease: Hye-Young Sung, Jeong-Wook Park, Joong-Seok Kim; J Mov Disord. 2014;7(1):7-12. Published online April 30, 2014; DOI: https://doi.org/10.14802/jmd.14002

17,973 View
178 Download
56 Citations

Abstract PDF

Objective: Although gastrointestinal dysfunctions occur in the majority of patients with Parkinson’s disease (PD), they are often unrecognized because many patients remain relatively asymptomatic in the early stage. We investigated the frequency of gastrointestinal symptoms in patients with PD using newly developed gastrointestinal symptom questionnaires.
Methods: Early PD patients with a symptom duration not exceeding 3 years were included in this study. All PD patients were evaluated using a questionnaire, which consisted of three relevant domains: oropharyngoesophageal (10 items); gastric (3 items); and intestinal-anorectal (7 items). The frequency of symptoms was calculated as a proportion with an item score ≥ 2.
Results: Of the 54 patients enrolled, 48 patients (88.9%) responded that bowel symptoms developed before the onset of Parkinsonian motor symptoms, and four patients reported that the onset of two types of symptoms (i.e., bowel and neurological) occurred approximately simultaneously, with only months between them. The frequencies of gastrointestinal symptoms are as follows: speech disturbance (40.7%), drooling (24.1%), sense of getting stuck (31.5%), choking (27.8%), globus pharyngis (16.7%), repetitive deglutition (29.6%), pain during swallowing (5.6%), food regurgitation (3.7%), acid reflux (7.4%), nausea/ vomiting (11.1%), early satiety (16.7%), postprandial fullness (14.8%), epigastric soreness (9.3%), abdominal pain (3.7%), constipation (46.3%), excessive strain during defecation (33.3%), fecal incontinence (7.4%), tenesmus (20.4%), loose stool or diarrhea (3.7%), and difficulty in relaxing anal sphincter (11.1%). Two patients were scored at zero.
Conclusions: Our findings confirm that gastrointestinal dysfunction occurs in early PD in relatively high frequency.

Citations

Citations to this article as recorded by

Persistent intolerable abdominal pain in patients with Parkinson’s disease
Hiroshi Kataoka, Kazuma Sugie
Clinical Neurology and Neurosurgery.2023; 224: 107558. CrossRef
Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim
Clinical Nuclear Medicine.2023; 48(2): 143. CrossRef
The gut microbiota is an emerging target for improving brain health during ageing
Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox
Gut Microbiome.2023;[Epub] CrossRef
6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease
Maria Del Pilar Murillo, Ebba Johansson, Victoria Bryntesson, Patrik Aronsson, Gunnar Tobin, Michael Winder, Thomas Carlsson, Stephen Fink
Gastroenterology Research and Practice.2023; 2023: 1. CrossRef
Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial
Ying-Jia Li, Ian-I Leong, Jing-Qi Fan, Ming-Yue Yan, Xin Liu, Wei-Jing Lu, Yuan-Yuan Chen, Wei-Qiang Tan, Yu-Ting Wang, Li-Xing Zhuang
Frontiers in Neuroscience.2023;[Epub] CrossRef
Considerations for developing a targeted amino acid supplement for people with Parkinson’s disease that promotes health while accounting for pathophysiology and medication interference
Jacob E Earp, Cristina Colon-Semenza, Dara L LoBuono
Nutrition Reviews.2023; 81(8): 1063. CrossRef
Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis
Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen, Fengwei Tian
Nutrients.2023; 15(7): 1737. CrossRef
The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study
Charlotte B. Stewart, David Ledingham, Victoria K. Foster, Kirstie N. Anderson, Sahana Sathyanarayana, Debra Galley, Nicola Pavese, Jacopo Pasquini
Frontiers in Neurology.2023;[Epub] CrossRef
Association of dysphagia with altered brain glucose metabolism in Parkinson's disease
Ji Yeon Oh, Eui Jin An, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim
CNS Neuroscience & Therapeutics.2023; 29(9): 2498. CrossRef
Differential Findings on Anorectal Manometry in Patients with Parkinson's Disease and Defecatory Dysfunction
Wendy Zhou, George Triadafilopoulos, Brooke Gurland, Houssam Halawi, Laren Becker, Patricia Garcia, Linda Nguyen, Mitchell Miglis, Srikanth Muppidi, Dong‐In Sinn, Safwan Jaradeh, Leila Neshatian
Movement Disorders Clinical Practice.2023; 10(7): 1074. CrossRef
Abdominal pain in Parkinson’s disease
A.A. Pilipovich, O.V. Vorobyova, S.A. Makarov
Russian Journal of Pain.2023; 21(2): 12. CrossRef
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo
CNS & Neurological Disorders - Drug Targets.2023; 22(9): 1355. CrossRef
Constipation in Parkinson's Disease
Eamonn M. M. Quigley
Seminars in Neurology.2023; 43(04): 562. CrossRef
Neuroimmune Connectomes in the Gut and Their Implications in Parkinson’s Disease
Beatriz Thomasi, Luisa Valdetaro, Brian Gulbransen, Ana Lúcia Tavares-Gomes
Molecular Neurobiology.2023;[Epub] CrossRef
Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis
Yuansen Li, Deshenyue Kong, Ke Bi, Huayou Luo
Frontiers in Medicine.2022;[Epub] CrossRef
Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum
Alexandra D. Zinnen, Jonathan Vichich, Jeanette M. Metzger, Julia C. Gambardella, Viktoriya Bondarenko, Heather A. Simmons, Marina E. Emborg, Stephan N. Witt
PLOS ONE.2022; 17(6): e0269190. CrossRef
Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
Roongroj Bhidayasiri, Warongporn Phuenpathom, Ai Huey Tan, Valentina Leta, Saisamorn Phumphid, K. Ray Chaudhuri, Pramod Kumar Pal
Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches
E.A. Katunina, N.N. Shipilova, D.A. Katunin
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(8): 21. CrossRef
Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
Huijia Yang, Song Li, Weidong Le
Aging and disease.2022; 13(5): 1381. CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
Yasir Bashir, Asad U. Khan
Frontiers in Neuroscience.2022;[Epub] CrossRef
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease
Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao
World Journal of Gastrointestinal Pharmacology and Therapeutics.2021; 12(1): 21. CrossRef
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort
Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Alfred Chin Yen Tay, Samantha Winter, Frank L. Mastaglia, Ryan S. Anderton
Movement Disorders Clinical Practice.2021; 8(2): 245. CrossRef
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat
Cynthia Kwan, Imane Frouni, Dominique Bédard, Adjia Hamadjida, Philippe Huot
Behavioural Pharmacology.2021; 32(1): 43. CrossRef
Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status
Luciana Grolli Ardenghi, Alana Verza Signorini, Gerson Schulz Maahs, Fabio Selaimen, Konrado Massing Deutsch, Silvia Dornelles, Carlos Roberto de Mello Rieder
International Archives of Otorhinolaryngology.2021; 25(01): e41. CrossRef
Spectrum of Non-Motor Symptoms in Parkinson's Disease
Maithrayie Kumaresan, Safeera Khan
Cureus.2021;[Epub] CrossRef
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans
Gregory D. Scott, Miranda M. Lim, Matthew G. Drake, Randy Woltjer, Joseph F. Quinn
Movement Disorders.2021; 36(9): 2094. CrossRef
The Gastrointestinal Dysfunction Scale for Parkinson's Disease
Marta Camacho, Julia C. Greenland, Caroline H. Williams‐Gray
Movement Disorders.2021; 36(10): 2358. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
Pharmacological Research.2021; 172: 105840. CrossRef
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
Katiane Roversi, Natalia Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot
Frontiers in Immunology.2021;[Epub] CrossRef
Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment
Zhichun Chen, Guanglu Li, Jun Liu
Neurobiology of Disease.2020; 134: 104700. CrossRef
Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
Ji‐Hyun Choi, Jee‐Young Lee, Jin Whan Cho, Seong‐Beom Koh, Young Soon Yang, Dalla Yoo, Cheol‐Min Shin, Hee Tae Kim
Movement Disorders.2020; 35(11): 1966. CrossRef
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri
Nature Reviews Gastroenterology & Hepatology.2020; 17(11): 673. CrossRef
Expanding the brain researcher's toolkit
Viviana Gradinaru
Science.2020; 369(6504): 637. CrossRef
Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
Olivier Rascol, Laurence Negre-Pages, Philippe Damier, Arnaud Delval, Pascal Derkinderen, Alain Destée, Margherita Fabbri, Wassilios G. Meissner, Amine Rachdi, François Tison, Santiago Perez-Lloret
Journal of Neural Transmission.2020; 127(12): 1607. CrossRef
Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom
Peter Urban, Bjorn Falkenburger, Wolfgang H. Jost, Gerhard Ransmayr, Peter Riederer, Christian Winkler
Fortschritte der Neurologie · Psychiatrie.2020; 88(09): 591. CrossRef
Parkinson’s disease: Are gut microbes involved?
Yogesh Bhattarai, Purna C. Kashyap
American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 319(5): G529. CrossRef
Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson’s Disease? Results of a Randomized Cross-Over Study
Guillaume Gourcerol, David Maltete, Nathalie Chastan, Marie Laure Welter, Anne Marie Leroi, Stéphane Derrey
Neuromodulation: Technology at the Neural Interface.2019; 22(4): 478. CrossRef
Probiotics for Parkinson’s Disease
Gazerani
International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats
Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch
PLOS ONE.2018; 13(1): e0190078. CrossRef
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
Fredric P. Manfredsson, Kelvin C. Luk, Matthew J. Benskey, Aysegul Gezer, Joanna Garcia, Nathan C. Kuhn, Ivette M. Sandoval, Joseph R. Patterson, Alana O'Mara, Reid Yonkers, Jeffrey H. Kordower
Neurobiology of Disease.2018; 112: 106. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
Meng-Fei Sun, Yan-Qin Shen
Ageing Research Reviews.2018; 45: 53. CrossRef
Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects
Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree
Current Treatment Options in Gastroenterology.2018; 16(4): 489. CrossRef
Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
Takashi Ogawa, Genko Oyama, Nobutaka Hattori
BMJ Case Reports.2018; : bcr-2017-223722. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
Neurological Sciences.2017; 38(1): 171. CrossRef
The Threshold Theory for Parkinson's Disease
Simone Engelender, Ole Isacson
Trends in Neurosciences.2017; 40(1): 4. CrossRef
Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives
Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer
Movement Disorders.2017; 32(1): 94. CrossRef
Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar
Advances in Parkinson's Disease.2017; 06(01): 1. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis
C.-H. Chen, C.-L. Lin, C.-H. Kao
Osteoporosis International.2016; 27(6): 2117. CrossRef
Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
Syed Ali, Ning Yin, Arkam Rehman, Verline Justilien
Medical Sciences.2016; 4(1): 1. CrossRef
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models
C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, M. Fornai
Neurogastroenterology & Motility.2016; 28(12): 1781. CrossRef
Gut dysfunction in Parkinson's disease
Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das
World Journal of Gastroenterology.2016; 22(25): 5742. CrossRef
Inflammation is genetically implicated in Parkinson’s disease
N. Dzamko, C.L Geczy, G.M Halliday
Neuroscience.2015; 302: 89. CrossRef
Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson’s disease rats
Xiaoli Zhang, Yun Li, Chenzhe Liu, Ruifang Fan, Ping Wang, Lifei Zheng, Feng Hong, Xiaoyan Feng, Yue Zhang, Lisheng Li, Jinxia Zhu
Translational Research.2015;[Epub] CrossRef
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
Jose L Barboza, Michael S Okun, Baharak Moshiree
Expert Opinion on Pharmacotherapy.2015; 16(16): 2449. CrossRef
Gastrointestinal Dysfunctions in Parkinson’s Disease
Joong-Seok Kim, Hey Young Sung
Journal of the Korean Neurological Association.2015; 33(4): 247. CrossRef

Author index